Member Info for bonker99

FWIW, I concur dude - give it a week/month and see what happens, no way are those results being ignored by those who count ... And keep an eye on dem MAs ;)

I don't think suggesting a buy at 3p qualifies as a ramp mate lol

removed - Napoleon is busy today eh ... So, anyway, I'll be adding again at 3p with my profits from elsewhere ...

Another stonker mate ;) Let em play it out to the end of the tape .....

The market has had the news for three hours mate - if we've just witnessed an attempt to fill large orders at c3p then anything can still happen - cracking moving averages setup here for the short-medium term imo ...

It's not a big reach to get to dementia from here mate is it? Anything that improves brain function puts that sort of stuff on the radar and jesus wept, like the market for stroke disability isn't big enough, that'd be the Viagra for the brain silver bullet ...

Tolerance levels are bound to be high imo as it's not a systemic treatment so that's no surprise to moi - 70% efficacy is outstanding though and, of course, as you're talking about a localised treatment here then the skill at applying that can only get better as time goes on - we're about as dumb as we'll ever be with this stuff right now so those are belting results imo ...

Here's my analysis mate - clinically relevant improvements in 7/10 patients - when does that ever happen? That's probably better than ibuprofen ffs ...

in cash plus those results - is there a bigger no-brainer out there??

.

MA200 touched @ 2.9p - who knows what happens next ...

then peeps - tell me htf I misread this one? Back at 3p - WTMF???????

Yup, I'm adding - the MAs are close enough to get us a Golden Cross here ...

fooked if I'm going to trade out @ 3p - coulda had more than that last week!

The biggy is the 61.8% @ 33p - who knows eh ...

she's gapping up to mid 3s then possible target of mid 8s is on for the initial drive??

:) The number I was looking for was the % patients with clinically significant responses and 71% (15/21) is an incredible number!!

Gap-ups at 4s/6s that progress may signpost it mate - I'll post more as and when it actually happens ;)

If the news is good and they gap her up I'm going to be taking a very keen interest indeed as to where they gap her up to mate cos the targets on offer here, over whatever timescale, are jaw dropping, like lottery win £large if she goes for it :)

immediately caught my attention here is the cash in bank being worth c2p and if that's the floor off not great results then buying at mid 2s as I did, heavily, a week or so ago looked well worth the punt. It may be the ultimate binary bet to the upside with relatively little downside which is why I went in so heavily. What also occurred to me is the commercialisation opportunity re stroke victims. No doubt, whoever "cures cancer" will be minted but an equal, if not greater, commercial argument could be made for "regenerative" treatments for illnesses that cause people to be a long-term burden on state resources given the nature of the crippling but not killing effect of those types of disease. That's a hard-nosed perspective to take I know but the fact of the matter is that if you die you stop costing the tax payer but if you're alive but crippled then you're a potentially heavy burden instead and there's an argument there to suggest that revenues from this type of treatment could be even greater than something that "merely" stops people from dying ...